Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,970,988
+$697,317 QoQ
Shares Held
2,477
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#2,135
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $82,370,025 across 15 Drug Manufacturers - General names. LLY ranks #4 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
271,250 | $68,257,350 | |
| 2 | JNJ |
Johnson & Johnson
|
14,678 | $3,727,771 | |
| 3 | AMGN |
Amgen Inc
|
8,630 | $3,125,095 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
2,477 | $2,970,988 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,792 | $2,928,772 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,582 | $957,909 | |
| 7 | PFE |
Pfizer Inc
|
10,065 | $242,365 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,153 | $66,435 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,970,988 | 2,477 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,273,671 | 2,472 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,652,310 | 2,468 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $1,875,454 | 2,458 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $1,916,084 | 2,458 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,036,694 | 2,466 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,767,108 | 2,289 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,033,232 | 2,295 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,066,982 | 2,283 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,761,301 | 2,264 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,317,399 | 2,260 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $1,208,005 | 2,249 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,043,011 | 2,224 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $748,999 | 2,181 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $789,116 | 2,157 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $693,585 | 2,145 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $382,267 | 1,179 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $333,907 | 1,166 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $311,023 | 1,126 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $256,234 | 1,109 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $235,946 | 1,028 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $172,434 | 923 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $152,800 | 905 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $133,958 | 905 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $59,597 | 363 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $50,355 | 363 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||